Literature DB >> 2445069

A highly sensitive method to assay FK-506 levels in plasma.

K Tamura1, M Kobayashi, K Hashimoto, K Kojima, K Nagase, K Iwasaki, T Kaizu, H Tanaka, M Niwa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2445069

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  75 in total

1.  Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients.

Authors:  A Jain; R Venkataramanan; S Todo; K Abu-Elmagd; J Fung; V Warty; A Tzakis; J Reyes; M Alessiani; T E Starzl
Journal:  Transplant Proc       Date:  1992-06       Impact factor: 1.066

2.  Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin.

Authors:  X Cai; J Harnaha; P N Rao; J Flowers; R Venkataramanan; V Warty; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1992-08       Impact factor: 1.066

Review 3.  FK 506 and autoimmune disease: perspective and prospects.

Authors:  A W Thomson; T E Starzl
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

4.  The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.

Authors:  J J Fung; M Eliasziw; S Todo; A Jain; A J Demetris; J P McMichael; T E Starzl; P Meier; A Donner
Journal:  J Am Coll Surg       Date:  1996-08       Impact factor: 6.113

5.  Assay of FK 506 in plasma.

Authors:  E M Cadoff; R Venkataramanan; A Krajack; A S Jain; J J Fung; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

6.  Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.

Authors:  A Zeevi; G Eiras; G Burckart; A Jain; A Kragack; R Venkataramanan; S Todo; J Fung; T E Starzl; R J Duquesnoy
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

7.  The effects of FK 506 on renal function after liver transplantation.

Authors:  J McCauley; J Fung; A Jain; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

8.  Suppression of autoimmune thyroid disease by FK 506: influence on thyroid-infiltrating cells, adhesion molecule expression and anti-thyroglobulin antibody production.

Authors:  K Tamura; J Woo; N Murase; G Carrieri; M A Nalesnik; A W Thomson
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

9.  Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506).

Authors:  K Abu-Elmagd; D H Van Thiel; B V Jegasothy; J C Jacobs; P Carroll; H Rodriquez-Rilo; C D Ackerman; J J Fung; T E Starzl
Journal:  Ann Intern Med       Date:  1993-10-01       Impact factor: 25.391

10.  Tacrolimus analysis: a comparison of different methods and matrices.

Authors:  V Warty; S Zuckerman; R Venkataramanan; J Lever; J Chao; T Mckaveney; J Fung; T Starzl
Journal:  Ther Drug Monit       Date:  1995-04       Impact factor: 3.681
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.